Navigation Links
Clarity on Cosmetic Injectable Labeling and Use
Date:4/14/2008

NEW YORK, April 14 /PRNewswire-USNewswire/ -- When it comes to cosmetic injectables, the terms "investigational" and "off-label" are often used interchangeably, often confusing consumers. The Physicians Coalition for Injectable Safety offers consumers these guidelines and definitions:

"A label containing specific consumer safety information is required by the Food and Drug Administration after a drug or medical device has been approved," explained Coalition leader Roger Dailey, MD of Portland, OR. "There are very specific labeling requirements including things such as brand name, drug content, the indications for a drug or device, dosing, adverse reactions, warnings and even data obtained from clinical studies."

A label defines the specific use for which a drug has been approved. "Off-label use refers to the legal practice of prescribing a drug for a purpose other than its stated indication; this is up to your doctors' discretion and is commonly done, however it is illegal for a manufacturer to market, advertise or otherwise promote the off-label use of drugs," said Coalition member Mark A. Codner, MD of Atlanta, GA. "For example, most dermal fillers are specifically approved for use in the nasolabial folds, the creases that run from the outer corner of the nose to the outer corner of the mouth. As a result, other forms of tissue enhancement that are commonly addressed with dermal fillers are considered 'off-label' as these specific treatments were not part of the clinical data submitted for approval," he continued.

"The term investigational means that either a drug or device is being studied in a particular application as part of the process necessary to submit for approval to the U.S. FDA, or that an approved drug or device is being studied for new uses," explained Dr. Dailey. "For example, consider that Botox(R) is approved for many clinical applications and Botox(R) Cosmetic is approved for cosmetic use. However, there is no app
'/>"/>

SOURCE Physicians Coalition for Injectable Safety
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Clarity for Consumers on Botox Complication and Death Reports
2. Experts Offer Clarity on Confusion Surrounding Stents
3. A New Kind of New Years Resolution Could Bring Clarity to Americans
4. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
5. Dr. Edmund Kwan to Speak on Facial Contouring Among Asian Patients at Cosmetic Surgery Seminar
6. Cosmetic Plastic Surgery Procedures for Ethnic Patients up 13 Percent in 2007
7. 2007 procedural survey reveals a 2 year increase in age of patients seeking cosmetic surgery
8. 2007 Procedural Survey Reveals a Two Year Increase in Age of Patients Seeking Cosmetic Surgery
9. Founding Father of Modern Cosmetic Dermatology Seeks to Warn Public of Misrepresented Data and Inappropriate Use of Botox
10. PreMD Inc. Signs Agreement with Cosmetics Conglomerate
11. Leading Natural Cosmetics Company Supports Breast Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Launches Orphan Drug Workshop at KGI 2Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Engineers doctors at UCLA develop novel material that could help fight arterial disease 62158 1Engineers doctors at UCLA develop novel material that could help fight arterial disease 62158 2Engineers doctors at UCLA develop novel material that could help fight arterial disease 62158 3Engineers doctors at UCLA develop novel material that could help fight arterial disease 62158 4Centegra H1N1 Vaccination Clinics to Resume Tuesday Dec 1 62154 1Centegra H1N1 Vaccination Clinics to Resume Tuesday Dec 1 62154 2Centegra H1N1 Vaccination Clinics to Resume Tuesday Dec 1 62154 3Centegra H1N1 Vaccination Clinics to Resume Tuesday Dec 1 62154 4MISSION Skincare 28R 29 Supports GNCs Efforts To Raise Money for St Jude Childrens Research Hospital 28R 29 62150 1MISSION Skincare 28R 29 Supports GNCs Efforts To Raise Money for St Jude Childrens Research Hospital 28R 29 62150 2